Erratum: Identification and Characterization of a Novel Small-Molecule Inhibitor of β-Catenin Signaling ((2014) 184 (2111-2122) DOI: 10.1016/j.ajpath.2014.04.002);Identification and characterization of a novel small-molecule inhibitor of β-catenin signaling

American Journal of Pathology

Volumn 184, Issue 7, 2014, Pages 2111-2122

  Delgado, Evan R ^a   Yang, Jing ^a   So, Juhoon ^a   Leimgruber, Stephanie ^b   Kahn, Michael ^c   Ishitani, Tohru ^d   Shin, Donghun ^a   Mustata Wilson, Gabriela ^e   Monga, Satdarshan P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d KYUSHU UNIVERSITY   (Japan)

^e UNIVERSITY OF SOUTHERN INDIANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; BETA CATENIN INHIBITOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GREEN FLUORESCENT PROTEIN; ICG 001; PHOSPHOTRANSFERASE; PMED 1; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; CTNNB1 PROTEIN, HUMAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; FUSED HETEROCYCLIC RINGS; N BENZYL 1,2,3,4,8,9 HEXAHYDRO 6 (4 HYDROXYBENZYL) 8 (1 NAPHTHYLMETHYL) 4,7 DIOXO 2H PYRAZINO[1,2 A]PYRIMIDINE 1(6H) CARBOXAMIDE; PYRIMIDINONE DERIVATIVE;

ADULT; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CTNNB1 GENE; EMBRYO; GENE MUTATION; HEPATOBLASTOMA; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ZEBRA FISH; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG DEVELOPMENT; DRUG EFFECTS; IC50; LIVER TUMOR; METABOLISM; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; BICYCLO COMPOUNDS, HETEROCYCLIC; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CREB-BINDING PROTEIN; DRUG DISCOVERY; HUMANS; INHIBITORY CONCENTRATION 50; LIVER NEOPLASMS; PYRIMIDINONES; STRUCTURE-ACTIVITY RELATIONSHIP; WNT SIGNALING PATHWAY; ZEBRAFISH;

EID: 84903198182     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.04.002     Document Type: Erratum

References (35)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. J.D. Yang, and L.R. Roberts Hepatocellular carcinoma: A global view Nat Rev Gastroenterol Hepatol 7 2010 448 458
3. B.E. Fortune, V. Umman, T. Gilliland, and S. Emre Liver transplantation for hepatocellular carcinoma: A surgical perspective J Clin Gastroenterol 47 Suppl 2013 S37 S42
4. H. Imamura, Y. Matsuyama, E. Tanaka, T. Ohkubo, K. Hasegawa, S. Miyagawa, Y. Sugawara, M. Minagawa, T. Takayama, S. Kawasaki, and M. Makuuchi Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy J Hepatol 38 2003 200 207
5. K. Suzuki, N. Kono, A. Ono, Y. Osuga, H. Kiyokawa, I. Mineo, Y. Matsuda, S. Miyoshi, S. Kawata, Y. Minami, K. Moriwaki, and S. Tarui Transcatheter arterial chemo-embolization for humoral hypercalcemia of hepatocellular carcinoma Gastroenterol Jpn 23 1988 29 36
6. P. Stock, D. Monga, X. Tan, A. Micsenyi, N. Loizos, and S.P. Monga Platelet-derived growth factor receptor-alpha: A novel therapeutic target in human hepatocellular cancer Mol Cancer Ther 6 2007 1932 1941
7. I.O. Ng, R.T. Poon, J.M. Lee, S.T. Fan, M. Ng, and W.K. Tso Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma Am J Clin Pathol 116 2001 838 845
8. D.K. Dhar, H. Naora, A. Yamanoi, T. Ono, H. Kohno, H. Otani, and N. Nagasue Requisite role of VEGF receptors in angiogenesis of hepatocellular carcinoma: A comparison with angiopoietin/Tie pathway Anticancer Res 22 2002 379 386
9. F. Bronte, G. Bronte, S. Cusenza, E. Fiorentino, C. Rolfo, G. Cicero, E. Bronte, V. Di Marco, A. Firenze, G. Angarano, T. Fontana, and A. Russo Targeted therapies in hepatocellular carcinoma Curr Med Chem 21 2014 966 974
10. K.N. Nejak-Bowen, and S.P. Monga Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad Semin Cancer Biol 21 2011 44 58
11. J. Behari, G. Zeng, W. Otruba, M.D. Thompson, P. Muller, A. Micsenyi, S.S. Sekhon, L. Leoni, and S.P. Monga R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells J Hepatol 46 2007 849 857
12. E. Delgado, R. Bahal, J. Yang, J.M. Lee, D.H. Ly, and S.P. Monga β-Catenin knockdown in liver tumor cells by a cell permeable gamma guanidine-based peptide nucleic acid Curr Cancer Drug Targets 13 2013 867 878
13. S.M. Huang, Y.M. Mishina, S. Liu, A. Cheung, F. Stegmeier, and G.A. Michaud et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling Nature 461 2009 614 620
14. M.D. Thompson, M.J. Dar, and S.P. Monga Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of beta-catenin J Hepatol 54 2011 506 512
15. G. Zeng, U. Apte, B. Cieply, S. Singh, and S.P. Monga siRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survival Neoplasia 9 2007 951 959
16. K.H. Emami, C. Nguyen, H. Ma, D.H. Kim, K.W. Jeong, M. Eguchi, R.T. Moon, J.L. Teo, H.Y. Kim, S.H. Moon, J.R. Ha, and M. Kahn A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [Erratum appeared in Proc Natl Acad Sci USA 2004, 101:16707] Proc Natl Acad Sci USA 101 2004 12682 12687
17. F. Takahashi-Yanaga, and M. Kahn Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin Cancer Res 16 2010 3153 3162
18. A.N. Jain Morphological similarity: A 3D molecular similarity method correlated with protein-ligand recognition J Comput Aided Mol Des 14 2000 199 213
19. Westerfield M: The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio), ed 4. University of Oregon Press, Eugene, 2000
20. N. Shimizu, K. Kawakami, and T. Ishitani Visualization and exploration of Tcf/Lef function using a highly responsive Wnt/beta-catenin signaling-reporter transgenic zebrafish Dev Biol 370 2012 71 85
21. Y.C. Martin, J.L. Kofron, and L.M. Traphagen Do structurally similar molecules have similar biological activity? J Med Chem 45 2002 4350 4358
22. A. Wallqvist, R. Huang, N. Thanki, and D.G. Covell Evaluating chemical structure similarity as an indicator of cellular growth inhibition J Chem Inf Model 46 2006 430 437
23. J.J. Irwin, T. Sterling, M.M. Mysinger, E.S. Bolstad, and R.G. Coleman ZINC: A free tool to discover chemistry for biology J Chem Inf Model 52 2012 1757 1768
24. G. Carruba, M. Cervello, M.D. Miceli, R. Farruggio, M. Notarbartolo, L. Virruso, L. Giannitrapani, R. Gambino, G. Montalto, and L. Castagnetta Truncated form of beta-catenin and reduced expression of wild-type catenins feature HepG2 human liver cancer cells Ann N Y Acad Sci 886 1999 212 216
25. A. Lochner, and J.A. Moolman The many faces of H89: A review Cardiovasc Drug Rev 24 2006 261 274
26. N. Ibrahim, Y. Yu, W.R. Walsh, and J.L. Yang Molecular targeted therapies for cancer: sorafenib mono-therapy and its combination with other therapies (review) Oncol Rep 27 2012 1303 1311
27. S.P. Monga Role of Wnt/β-catenin signaling in liver metabolism and cancer Int J Biochem Cell Biol 43 2011 1021 1029
28. A. Cadoret, C. Ovejero, B. Terris, E. Souil, L. Lévy, W.H. Lamers, J. Kitajewski, A. Kahn, and C. Perret New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism Oncogene 21 2002 8293 8301
29. S. Loeppen, D. Schneider, F. Gaunitz, R. Gebhardt, R. Kurek, A. Buchmann, and M. Schwarz Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital Cancer Res 62 2002 5685 5688
30. H. Ma, C. Nguyen, K.S. Lee, and M. Kahn Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression Oncogene 24 2005 3619 3631
31. K.N. Nejak-Bowen, M.D. Thompson, S. Singh, W.C. Bowen Jr., M.J. Dar, J. Khillan, C. Dai, and S.P. Monga Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin Hepatology 51 2010 1603 1613
32. X. Tan, J. Behari, B. Cieply, G.K. Michalopoulos, and S.P. Monga Conditional deletion of beta-catenin reveals its role in liver growth and regeneration Gastroenterology 131 2006 1561 1572
33. H. Yao, E. Ashihara, J.W. Strovel, Y. Nakagawa, J. Kuroda, R. Nagao, R. Tanaka, A. Yokota, M. Takeuchi, Y. Hayashi, C. Shimazaki, M. Taniwaki, K. Strand, J. Padia, H. Hirai, S. Kimura, and T. Maekawa AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model Blood Cancer J 1 2011 e43
34. Y. Hoshida, S. Toffanin, A. Lachenmayer, A. Villanueva, B. Minguez, and J.M. Llovet Molecular classification and novel targets in hepatocellular carcinoma: recent advancements Semin Liver Dis 30 2010 35 51
35. P. Teriete, A.B. Pinkerton, and N.D. Cosford Inhibitors of tissue-nonspecific alkaline phosphatase (TNAP): from hits to leads Methods Mol Biol 1053 2013 85 101